Taiyen Biotech Financials
| 1737 Stock | TWD 32.30 0.05 0.15% |
Taiyen |
Understanding current and past Taiyen Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Taiyen Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Taiyen Biotech's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Taiyen Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Taiyen Biotech Co. Check Taiyen Biotech's Beneish M Score to see the likelihood of Taiyen Biotech's management manipulating its earnings.
Taiyen Biotech Stock Summary
Taiyen Biotech competes with Taiwan Fertilizer, Uni President, Great Wall, Lien Hwa, and Standard Foods. Taiyen Biotech Co., Ltd. provides various health and beauty products under the TAIYEN brand Hong Kong, Taiwan, Mainland China, and Macau. The company was founded in 1952 and is based in Tainan, Taiwan. TAIYEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0001737005 |
| Business Address | No 297, Chien-Kang |
| Sector | Food Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.tybio.com.tw |
| Phone | 886 6 2160 688 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Taiyen Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Taiyen Stock, because this is throwing your money away. Analyzing the key information contained in Taiyen Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Taiyen Biotech Key Financial Ratios
There are many critical financial ratios that Taiyen Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Taiyen Biotech reports annually and quarterly.| Return On Equity | 0.0642 | |||
| Return On Asset | 0.0346 | |||
| Number Of Employees | 33 | |||
| Beta | 0.22 | |||
| Z Score | 73.8 |
Taiyen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Taiyen Biotech's current stock value. Our valuation model uses many indicators to compare Taiyen Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Taiyen Biotech competition to find correlations between indicators driving Taiyen Biotech's intrinsic value. More Info.Taiyen Biotech Co is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Taiyen Biotech Co is roughly 1.86 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Taiyen Biotech's earnings, one of the primary drivers of an investment's value.Taiyen Biotech Systematic Risk
Taiyen Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Taiyen Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Taiyen Biotech correlated with the market. If Beta is less than 0 Taiyen Biotech generally moves in the opposite direction as compared to the market. If Taiyen Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Taiyen Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Taiyen Biotech is generally in the same direction as the market. If Beta > 1 Taiyen Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Taiyen Biotech December 17, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Taiyen Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Taiyen Biotech Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Taiyen Biotech Co based on widely used predictive technical indicators. In general, we focus on analyzing Taiyen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Taiyen Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.41) | |||
| Maximum Drawdown | 2.81 | |||
| Value At Risk | (0.99) | |||
| Potential Upside | 0.7752 |
Additional Tools for Taiyen Stock Analysis
When running Taiyen Biotech's price analysis, check to measure Taiyen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taiyen Biotech is operating at the current time. Most of Taiyen Biotech's value examination focuses on studying past and present price action to predict the probability of Taiyen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taiyen Biotech's price. Additionally, you may evaluate how the addition of Taiyen Biotech to your portfolios can decrease your overall portfolio volatility.